MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 57 filers reported holding MEI PHARMA INC in Q3 2017. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $894,000 | -12.7% | 307,313 | -4.9% | 0.00% | -100.0% |
| Q2 2021 | $1,024,000 | +31.5% | 323,089 | +37.6% | 0.00% | 0.0% |
| Q1 2021 | $779,000 | +1.4% | 234,731 | -8.3% | 0.00% | 0.0% |
| Q4 2020 | $768,000 | +5020.0% | 255,843 | +5267.0% | 0.00% | – |
| Q3 2020 | $15,000 | -46.4% | 4,767 | -42.2% | 0.00% | – |
| Q2 2020 | $28,000 | +21.7% | 8,242 | -9.3% | 0.00% | – |
| Q4 2019 | $23,000 | +130.0% | 9,085 | +51.9% | 0.00% | – |
| Q3 2019 | $10,000 | -28.6% | 5,979 | +5.1% | 0.00% | – |
| Q2 2019 | $14,000 | -88.1% | 5,688 | -87.0% | 0.00% | – |
| Q3 2017 | $118,000 | -6.3% | 43,816 | -17.2% | 0.00% | – |
| Q2 2017 | $126,000 | +6200.0% | 52,892 | +17530.7% | 0.00% | – |
| Q2 2014 | $2,000 | -97.2% | 300 | -95.3% | 0.00% | – |
| Q1 2014 | $71,000 | +39.2% | 6,326 | 0.0% | 0.00% | – |
| Q4 2013 | $51,000 | -10.5% | 6,326 | +25.3% | 0.00% | – |
| Q3 2013 | $57,000 | +58.3% | 5,048 | 0.0% | 0.00% | – |
| Q2 2013 | $36,000 | – | 5,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,039,038 | $9,482,000 | 7.48% |
| Asymmetry Capital Management, L.P. | 787,359 | $2,457,000 | 1.58% |
| First Light Asset Management, LLC | 3,763,804 | $11,743,000 | 1.20% |
| NEA Management Company, LLC | 8,533,072 | $26,623,000 | 1.13% |
| Opaleye Management Inc. | 1,556,000 | $4,855,000 | 0.95% |
| BVF INC/IL | 4,080,162 | $12,730,000 | 0.69% |
| DAFNA Capital Management LLC | 666,000 | $2,078,000 | 0.68% |
| CAXTON CORP | 175,560 | $548,000 | 0.52% |
| Alambic Investment Management, L.P. | 12,500 | $39,000 | 0.43% |
| Boxer Capital, LLC | 2,913,091 | $9,089,000 | 0.31% |